Overall Survival with Durvalumab versus Placebo after Chemoradiotherapy in Stage III NSCLC: Updated Results from PACIFIC - de Wit, M; Schulz, C; Laack, HE; Wolff, T; Rückert, A; Faehling, M; Fischer, JR; Reck, M (Pneumologie, 2019)